Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 143 ($1.85) and traded as low as GBX 143 ($1.85). Amryt Pharma shares last traded at GBX 143 ($1.85), with a volume of 90,726 shares changing hands.
Amryt Pharma Stock Performance
The company has a market cap of £457.11 million and a PE ratio of -4.33. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05. The business has a fifty day moving average of GBX 143 and a 200-day moving average of GBX 143.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
See Also
- Five stocks we like better than Amryt Pharma
- The Risks of Owning Bonds
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What is a support level?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
